Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
图: 1 / 8
Positive Control: HeLa cell lysate, 293T cell lysate, Jurkat cell lysate, MCF7.
Tissue Specificity: Tissue enhanced (bone marrow, lymphoid tissue, testis).
Subcellular Location: Nucleus, Cytoplasm, cytoskeleton, microtubule organizing center, centrosome.
Sequence Similarities: 60% Mouse/Rat.
Predicted band size: 384 kDa.
Breast Cancer Type 2 susceptibility protein (BRCA2) is a tumor-suppressor protein reported to be involved in double-strand break repair, homologous recombination and S-phase checkpoint activation.
仅用于科研。不用于诊断过程。未经明确授权不得转售。
蛋白别名: brca 2; brca-2; BRCA1/BRCA2-containing complex, subunit 2; breast and ovarian cancer susceptibility gene, early onset; breast and ovarian cancer susceptibility protein 2; breast cancer 2 tumor suppressor; breast cancer 2, early onset; Breast cancer type 2 susceptibility protein; FANCB; Fanconi anemia group D1 protein; mutant BRCA2; RP11-298P3.4
基因别名: BRCA2; BRCC2; BROVCA2; FACD; FAD; FAD1; FANCD; FANCD1; GLM3; PNCA2; XRCC11
UniProt ID: (Human) P51587
Entrez Gene ID: (Human) 675